NO20005453D0 - N-(3-etynylfenylamino)-6,7-bis(2-metoksyetoksy)-4- quinazolinaminmesylatanhydrat og monohydrat - Google Patents

N-(3-etynylfenylamino)-6,7-bis(2-metoksyetoksy)-4- quinazolinaminmesylatanhydrat og monohydrat

Info

Publication number: NO20005453D0
Authority: NO; Norway
Prior art keywords: ethynylphenylamino; methoxyethoxy; monohydrate; bis; quinazolinamine mesylate
Prior art date: 1998-04-29

Application number

NO20005453A

Other languages

English (en)

Other versions

NO317301B1 (no

NO20005453L (no

Inventor

Douglas John Meldrum Allen

Timothy Norris

Jeffrey William Raggon

Dinos Paul Santafianos

Ravi Mysore Shanker

Original Assignee

Osi Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

2000-10-27

Publication date

2000-10-27

2000-10-27 Application filed by Osi Pharm Inc filed Critical Osi Pharm Inc

2000-10-27 Publication of NO20005453D0 publication Critical patent/NO20005453D0/no

2000-12-20 Publication of NO20005453L publication Critical patent/NO20005453L/no

2004-10-04 Publication of NO317301B1 publication Critical patent/NO317301B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20005453A 1998-04-29 2000-10-27 N-(3-etynylfenylamino)-6,7-bis(2-metoksyetoksy)-4-quinazolinamin mesylat anhydrat og monohydrat NO317301B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8344198P	1998-04-29	1998-04-29
PCT/IB1999/000612 WO1999055683A1 (en)	1998-04-29	1999-04-08	N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate

Publications (3)

Publication Number	Publication Date
NO20005453D0 true NO20005453D0 (no)	2000-10-27
NO20005453L NO20005453L (no)	2000-12-20
NO317301B1 NO317301B1 (no)	2004-10-04

Family

ID=22178359

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005453A NO317301B1 (no)	1998-04-29	2000-10-27	N-(3-etynylfenylamino)-6,7-bis(2-metoksyetoksy)-4-quinazolinamin mesylat anhydrat og monohydrat

Country Status (41)

Country	Link
EP (1)	EP1076652B1 (no)
JP (1)	JP4652569B2 (no)
KR (1)	KR100668412B1 (no)
CN (2)	CN101219999A (no)
AP (1)	AP1252A (no)
AR (1)	AR018201A1 (no)
AT (1)	ATE295839T1 (no)
AU (1)	AU759691C (no)
BR (1)	BR9910025A (no)
CA (1)	CA2330447C (no)
CO (1)	CO5060467A1 (no)
CZ (1)	CZ298230B6 (no)
DE (1)	DE69925366T2 (no)
DZ (1)	DZ2777A1 (no)
EA (1)	EA002836B1 (no)
EG (1)	EG24000A (no)
ES (1)	ES2238825T3 (no)
GT (1)	GT199900063A (no)
HN (1)	HN1999000057A (no)
HU (1)	HU227569B1 (no)
ID (1)	ID27198A (no)
IL (1)	IL139172A0 (no)
MA (1)	MA26624A1 (no)
ME (1)	MEP42008A (no)
MX (1)	MXPA00010610A (no)
MY (1)	MY136033A (no)
NO (1)	NO317301B1 (no)
NZ (1)	NZ508154A (no)
OA (1)	OA11769A (no)
PA (1)	PA8471001A1 (no)
PE (1)	PE20000441A1 (no)
PL (1)	PL196940B1 (no)
RS (1)	RS50081B (no)
SA (1)	SA99200216B1 (no)
TN (1)	TNSN99079A1 (no)
TR (1)	TR200003166T2 (no)
TW (1)	TWI248437B (no)
UA (1)	UA60363C2 (no)
UY (1)	UY26099A1 (no)
WO (1)	WO1999055683A1 (no)
ZA (1)	ZA992972B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6706721B1 (en)	1998-04-29	2004-03-16	Osi Pharmaceuticals, Inc.	N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
RS49836B (sr)	1999-03-31	2008-08-07	Pfizer Products Inc.,	Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja
UA74803C2 (uk) *	1999-11-11	2006-02-15	Осі Фармасьютікалз, Інк.	Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US7087613B2 (en)	1999-11-11	2006-08-08	Osi Pharmaceuticals, Inc.	Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA73993C2 (uk) *	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
EP1408980A4 (en)	2001-06-21	2004-10-20	Ariad Pharma Inc	NEW QUINAZOLINES AND THEIR USE
US7078409B2 (en)	2002-03-28	2006-07-18	Beta Pharma, Inc.	Fused quinazoline derivatives useful as tyrosine kinase inhibitors
GB0223854D0 (en) *	2002-10-12	2002-11-20	Astrazeneca Ab	Therapeutic treatment
US7148231B2 (en) *	2003-02-17	2006-12-12	Hoffmann-La Roche Inc.	[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
EP1633870B1 (en)	2003-05-30	2013-03-27	OncoTherapy Science, Inc.	Process for screening a drug response in cancer patients
BRPI0411126A (pt)	2003-06-10	2006-07-18	Hoffmann La Roche	derivados de 1,3,4-triaza-fenaleno e 1,3,4,6-tetraazafenaleno
GB0403744D0 (en)	2004-02-20	2004-03-24	Astrazeneca Ab	Chemical process
WO2005107747A2 (en)	2004-05-06	2005-11-17	Bioresponse, Llc	Diindolymethane formulations for the treatment of leiomyomas
US7989486B2 (en)	2004-12-30	2011-08-02	Bioresponse, L.L.C.	Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
WO2008012105A1 (en)	2006-07-28	2008-01-31	Synthon B.V.	Crystalline erlotinib
WO2008057253A2 (en)	2006-10-27	2008-05-15	Bioresponse, L.L.C.	Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
JP5524041B2 (ja) *	2007-04-04	2014-06-18	シプラ・リミテッド	エルロチニブおよびその薬学的に許容可能な塩の製造方法
WO2009007984A2 (en)	2007-07-11	2009-01-15	Hetero Drugs Limited	An improved process for erlotinib hydrochloride
EP2176241B1 (en)	2007-08-17	2015-12-23	Hetero Drugs Limited	A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
KR101132937B1 (ko) *	2008-10-01	2012-04-06	주식회사종근당	Ｎ-(3-에티닐페닐)-6,7-비스(2-메톡시에톡시)-4-퀴나졸린아민 납실레이트 염
WO2010109443A1 (en)	2009-03-26	2010-09-30	Ranbaxy Laboratories Limited	Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
WO2011068404A2 (en)	2009-12-02	2011-06-09	Ultimorphix Technologies B.V.	Administration of n-(3-ethynylphenylamino)-6,7-bis(2- methoxyethoxy)-4-quinazolinamine mesylate salt by inhalation
DE202010006543U1 (de)	2010-05-07	2010-09-09	Ratiopharm Gmbh	Erlotinibresinat
HU230483B1 (hu)	2011-10-10	2016-07-28	Egis Gyógyszergyár Nyrt.	Erlotinib sók
NZ630289A (en)	2012-09-04	2016-08-26	Shilpa Medicare Ltd	Crystalline erlotinib hydrochloride process

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ243082A (en) *	1991-06-28	1995-02-24	Ici Plc	4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
JP2994165B2 (ja) *	1992-06-26	1999-12-27	ゼネカ・リミテッド	キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤
GB9323290D0 (en) *	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives
ATE205483T1 (de) *	1995-03-30	2001-09-15	Pfizer	Chinazolinderivate
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines

1999
- 1999-04-08 CN CNA2008100051101A patent/CN101219999A/zh active Pending
- 1999-04-08 DE DE69925366T patent/DE69925366T2/de not_active Expired - Lifetime
- 1999-04-08 EP EP99909165A patent/EP1076652B1/en not_active Expired - Lifetime
- 1999-04-08 IL IL13917299A patent/IL139172A0/xx not_active IP Right Cessation
- 1999-04-08 RS YUP-661/00A patent/RS50081B/sr unknown
- 1999-04-08 WO PCT/IB1999/000612 patent/WO1999055683A1/en not_active Ceased
- 1999-04-08 ES ES99909165T patent/ES2238825T3/es not_active Expired - Lifetime
- 1999-04-08 TR TR2000/03166T patent/TR200003166T2/xx unknown
- 1999-04-08 KR KR1020007011998A patent/KR100668412B1/ko not_active Expired - Lifetime
- 1999-04-08 CZ CZ20003974A patent/CZ298230B6/cs not_active IP Right Cessation
- 1999-04-08 MX MXPA00010610A patent/MXPA00010610A/es active IP Right Grant
- 1999-04-08 ID IDW20002186A patent/ID27198A/id unknown
- 1999-04-08 OA OA1200000300A patent/OA11769A/en unknown
- 1999-04-08 CN CN99805497A patent/CN1298396A/zh active Pending
- 1999-04-08 AT AT99909165T patent/ATE295839T1/de not_active IP Right Cessation
- 1999-04-08 PL PL343766A patent/PL196940B1/pl not_active IP Right Cessation
- 1999-04-08 EA EA200001112A patent/EA002836B1/ru not_active IP Right Cessation
- 1999-04-08 JP JP2000545843A patent/JP4652569B2/ja not_active Expired - Lifetime
- 1999-04-08 HU HU0101818A patent/HU227569B1/hu unknown
- 1999-04-08 ME MEP-420/08A patent/MEP42008A/xx unknown
- 1999-04-08 NZ NZ508154A patent/NZ508154A/en not_active IP Right Cessation
- 1999-04-08 AU AU28509/99A patent/AU759691C/en not_active Expired
- 1999-04-08 BR BR9910025-8A patent/BR9910025A/pt not_active Application Discontinuation
- 1999-04-08 CA CA002330447A patent/CA2330447C/en not_active Expired - Lifetime
- 1999-04-23 TW TW088106555A patent/TWI248437B/zh not_active IP Right Cessation
- 1999-04-26 HN HN1999000057A patent/HN1999000057A/es unknown
- 1999-04-27 MY MYPI99001636A patent/MY136033A/en unknown
- 1999-04-27 AR ARP990101942A patent/AR018201A1/es active IP Right Grant
- 1999-04-27 PA PA19998471001A patent/PA8471001A1/es unknown
- 1999-04-28 DZ DZ990077A patent/DZ2777A1/xx active
- 1999-04-28 TN TNTNSN99079A patent/TNSN99079A1/fr unknown
- 1999-04-28 ZA ZA9902972A patent/ZA992972B/xx unknown
- 1999-04-28 MA MA25557A patent/MA26624A1/fr unknown
- 1999-04-29 PE PE1999000356A patent/PE20000441A1/es not_active Application Discontinuation
- 1999-04-29 CO CO99026003A patent/CO5060467A1/es unknown
- 1999-04-29 GT GT199900063A patent/GT199900063A/es unknown
- 1999-04-29 EG EG48299A patent/EG24000A/xx active
- 1999-04-29 AP APAP/P/1999/001523A patent/AP1252A/en active
- 1999-06-02 SA SA99200216A patent/SA99200216B1/ar unknown
- 1999-08-04 UA UA2000116681A patent/UA60363C2/uk unknown
2000
- 2000-04-05 UY UY26099A patent/UY26099A1/es not_active Application Discontinuation
- 2000-10-27 NO NO20005453A patent/NO317301B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EA002836B1 (ru)	2002-10-31
CZ298230B6 (cs)	2007-08-01
PE20000441A1 (es)	2000-05-23
ZA992972B (en)	2000-10-30
JP2002513009A (ja)	2002-05-08
HU227569B1 (en)	2011-08-29
CN101219999A (zh)	2008-07-16
KR100668412B1 (ko)	2007-01-12
MY136033A (en)	2008-07-31
ES2238825T3 (es)	2005-09-01
AP9901523A0 (en)	1999-06-30
PL343766A1 (en)	2001-09-10
CA2330447C (en)	2009-06-30
ATE295839T1 (de)	2005-06-15
JP4652569B2 (ja)	2011-03-16
ID27198A (id)	2001-03-08
DE69925366D1 (de)	2005-06-23
HN1999000057A (es)	1999-09-29
GT199900063A (es)	2000-10-20
AU759691C (en)	2004-04-29
BR9910025A (pt)	2000-12-26
CO5060467A1 (es)	2001-07-30
NO317301B1 (no)	2004-10-04
EP1076652B1 (en)	2005-05-18
DE69925366T2 (de)	2006-03-09
DZ2777A1 (fr)	2003-12-01
TNSN99079A1 (fr)	2005-11-10
KR20010078710A (ko)	2001-08-21
UY26099A1 (es)	2001-12-28
YU66100A (sh)	2003-07-07
RS50081B (sr)	2009-01-22
MEP42008A (en)	2011-02-10
AP1252A (en)	2004-02-25
CN1298396A (zh)	2001-06-06
TWI248437B (en)	2006-02-01
TR200003166T2 (tr)	2001-02-21
EG24000A (en)	2008-03-19
AU759691B2 (en)	2003-04-17
NZ508154A (en)	2003-07-25
NO20005453L (no)	2000-12-20
OA11769A (en)	2005-07-25
HUP0101818A1 (hu)	2002-03-28
AU2850999A (en)	1999-11-16
PA8471001A1 (es)	2000-09-29
HK1037180A1 (en)	2002-02-01
WO1999055683A1 (en)	1999-11-04
IL139172A0 (en)	2001-11-25
UA60363C2 (uk)	2003-10-15
CZ20003974A3 (en)	2001-05-16
AR018201A1 (es)	2001-10-31
CA2330447A1 (en)	1999-11-04
EA200001112A1 (ru)	2001-04-23
PL196940B1 (pl)	2008-02-29
MA26624A1 (fr)	2004-12-20
HUP0101818A3 (en)	2002-05-28
EP1076652A1 (en)	2001-02-21
MXPA00010610A (es)	2002-07-02
SA99200216B1 (ar)	2006-06-04

Publication	Publication Date	Title
NO20005453D0 (no)	2000-10-27	N-(3-etynylfenylamino)-6,7-bis(2-metoksyetoksy)-4- quinazolinaminmesylatanhydrat og monohydrat
IS6359A (is)	2002-04-24	Stöðugur fjölgervingur N-(3-etynýlfenýlamínó)-6,7-bis(2-metoxýetoxý)-4-qínazólínamín hýdróklíríðs, aðferð við framleiðslu hans og lyfjanotkun
DE69940128D1 (de)	2009-01-29	Chinazolin- und Pyridopyrimidinderivate
NO20000487D0 (no)	2000-01-31	Substituerte quinazolinderivater og anvendelse derav som tyrosin kinase inhibitorer
DE60017179D1 (de)	2005-02-03	Tyrosin kinaseinhibitoren
ATE269701T1 (de)	2004-07-15	Gyrase-inhibitoren und ihre verwendung
AU1047402A (en)	2002-03-22	Quinoline and quinazoline derivatives
DE60234376D1 (de)	2009-12-24	3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
EP1164733A4 (en)	2009-03-11	Channel constructing method and base station using the method
FI991505L (fi)	2000-01-04	Siruantenni ja siruantennilla varustettu radiolaite
DK1676845T3 (da)	2008-09-15	Nye quinazolinderivater
NO20031268D0 (no)	2003-03-19	4-aminokinazoliner
NO20012473D0 (no)	2001-05-18	Kinolin-4-karboksamidderivater som NK-3 og NK-2 reseptor antagonister
NO20022862L (no)	2002-07-19	Antennemast og innretning for innstilling av antenneorienteringer
DE60122160D1 (de)	2006-09-21	Antennenstruktur und zugehöriges verfahren
ATE227724T1 (de)	2002-11-15	Muscarinagonisten und antagonisten
NO20035573L (no)	2004-02-16	Kinazolinderivater
NO20031267L (no)	2003-05-19	4-aminokinazoliner
PT1268468E (pt)	2004-01-30	Mesilato de 4-amino-6,7dimetoxi-2- (5-metanossulfonamido-1,2,3,4-tetra-hidro-2-isoquinolil)5-5(2-piridil-quinazolina e polimorfos
DE10195304D2 (de)	2003-10-23	Chinolin-Derivative und ihre Verwendung
NO20021475D0 (no)	2002-03-25	Vasopressinantagonist, formulering og fremgangsmåte
DK1122253T3 (da)	2005-09-26	Quinazolinonderivater
KR980000611U (ko)	1998-03-30	야광, 축광 버티칼 및 롤 스크린

Legal Events

Date	Code	Title	Description
2013-12-02	MM1K	Lapsed by not paying the annual fees